• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to navigation
Close Ad

The Spoon

Daily news and analysis about the food tech revolution

  • Home
  • News
    • Alternative Protein
    • Business of Food
    • Connected Kitchen
    • COVID-19
    • Delivery & Commerce
    • Foodtech
    • Food Waste
    • Future of Drink
    • Future Food
    • Future of Grocery
    • Podcasts
    • Startups
    • Restaurant Tech
    • Robotics, AI & Data
  • Spoon Plus Central
  • Events
  • Newsletter
  • Connect
    • Send us a Tip
    • Spoon Newsletters
    • Slack
    • RSS
    • The Spoon Food Tech Survey Panel
  • Advertise
  • About
    • Staff
  • Become a Member
The Spoon
  • Home
  • News
    • Alternative Protein
    • Business of Food
    • Connected Kitchen
    • Foodtech
    • Food Waste
    • Future Food
    • Future of Grocery
    • Restaurant Tech
    • Robotics, AI & Data
  • Spoon Plus Central
  • Newsletter
  • Events
  • Jobs
  • Slack
  • Advertise
  • About
  • Become a Member

Finless Foods

June 20, 2018

Finless Foods Raises $3.5 Million for Cultured Bluefin Tuna

Today cultured seafood company Finless Foods CEO & Co-founder Mike Selden wrote a piece on Medium announcing that they had closed a $3.5 million seed round. The round was led by Draper Associates, with participation from Softmatter VC, Blue Horizon, Hemisphere Ventures, Yakumi Investment and more.

In the piece, Selden wrote that this invesment would bring them “to the end of our initial R&D phase,” and give them “the tools necessary to move into production pending the closing of a Series A.”

Finless Foods uses cellular biology to grow fish (and, eventually, other seafood) in bioreactors. They’re doing similar work to Memphis Meats or JUST Foods, but are focused on fish instead of meat. Wild Type is another startup using cellular agriculture to develop seafood (specifically salmon) grown outside the animal, and similarly raised $3.5 million a few months ago.

The company got its start in the legendary IndieBio accelerator program in 2017, where they created the first fish product grown in a lab. They later got investment from Hatch, a Norwegian aquaculture accelerator, as well as Hi-Food, an Italian company focused on sustainability in food.

Their first product will be bluefin tuna, a species which is threatened with overfishing. They plan to bring it to market by the end of 2019 — and with this funding, they just got a lot closer to that goal.

February 1, 2018

Lab-Grown Meat Just Got Another Shot of Investment

This week, Tyson Foods’ venture capital arm invested an undisclosed sum into San Francisco-based Memphis Meats, who is one of a few different companies developing lab-grown, cultured-meat alternatives.

Tyson joins DFJ Venture Capital, Bill Gates, Atomico, billionaires Suzy and Jack Welch, and several other investors. Those parties, along with heavyweight food producer Cargill, led a Series A funding round for Memphis Meats this past August that totaled $22 million.

Memphis Meats unveiled the world’s first cultured meatball in 2016, which was followed by the world’s first cultured poultry in 2017. The goal behind such products, along with those from companies like Mosa Meats, Finless Foods, SuperMeat, and Hampton Creek, is to offer consumers all the benefits of real meat without the environmental damages and foodborne illnesses associated with it.

To get it’s product, Memphis Meats uses on an ingredient called fetal bovine serum, a fascinating and slightly gross substance extracted from cow fetuses. The process of using fetal bovine serum won’t win the vegans over anytime soon, but it does enable the creation of an animal protein without the greenhouse gasses, deforestation, and host of other issues associated with raising livestock.

But cultured meat is expensive to produce, whether using fetal bovine serum or an animal-free method, as Memphis Meats is purportedly working on. Consider Mosa’s 1.2 million-per-pound lab-grown burger unveiled in 2013. And while the price of cultured meat is said to have dropped 99% since then, it’s still not low enough to make these products truly scalable (unless you’re okay with $6,000 chickens).

It’s technology that will eventually enable that scale. SuperMeat, for example, is developing technology to eliminate the need for animal serum. Finless Foods, meanwhile, has slashed prices by 50 percent and plans to have an affordable lab-grown bluefin tuna available by 2019. Memphis Meats aims to bring its product to market in 2021.

Lower costs will also make cultured meat a more realistic competitor to traditional meat products. Consumers spend about $1 trillion on meat globally, and demand is expected to double over the next few decades. Many are also betting on taste as the element that will convince traditional meat eaters to try alternatives. But it seems likely that alternative-meat producers will also need to offer competitively priced products in order to entice grill masters, tailgaters, and other die-hards.

I expect the future of alterna meat will be a combination of both lab-grown and plant-based products. Tyson’s investment in Memphis Meats also suggests we may see some acquisitions in the future, as more and more companies look to combine traditional meat products with science and technology to give the world its much-needed calories.

Primary Sidebar

Footer

  • About
  • Sponsor the Spoon
  • The Spoon Events
  • Spoon Plus

© 2016–2021 The Spoon. All rights reserved.

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube